Psoriatic Arthritis (PsA) Treatment Market

Psoriatic Arthritis (PsA) Treatment Market - Global Industry Assessment & Forecast

Healthcare

# Pages:

214

Base Year:

2024

Nov - 2024

Format:

Report Code:

VMR-3519

Segments Covered

By Drug Class Nonsteroidal Anti-inflammatory Drugs (NSAIDs), Disease-Modifying Antirheumatic Drugs (DMARDs), Biologics and Biosimilars, Corticosteroids, Others (PDE4 Inhibitors)
By Type of Treatment Prescription-based, Over-the-Counter (OTC)
By Route of Administration Oral, Injectable, Topical
By Distribution Channel Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
By Region North America, Europe, Asia Pacific, Latin America, Middle East & Africa

Standard License

$ 4299 USD

Multi User License

$ 6599 USD

Enterprise License

$ 6999 USD

Snapshot

Base Year:	2024
Forecast Years:	2025 - 2034
Historical Years:	2019 - 2023
Revenue 2024:	USD 24.01 Billion
Revenue 2034:	USD 50.45 Billion
Revenue CAGR (2025 - 2034):	8.6%
Fastest Growing Region (2025 - 2034)	North America
Largest Region (2024):	North America

Customization Offered

Cross-segment Market Size and Analysis for Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market Dynamics
Region Level Market Share
Import Export Analysis
Production Analysis
Others Request Customization Speak To Analyst

Executive Dashboard
1. Strategic Imperatives
Premium Insights
1. Top 3 Trends to Watch
2. Demand and Supply Trends
3. Top 3 Strategies Followed by Major Players
4. Top 3 Predictions by Vantage Market Research
5. Top Investment Pockets
6. Insights from Primary Respondents
Global Psoriatic Arthritis (PsA) Treatment Market - Segment Analysis
1. Overview
2. Global Psoriatic Arthritis (PsA) Treatment Market, 2016 - 2028 (USD Million)
3. Global Psoriatic Arthritis (PsA) Treatment Market - by Drug Class
  1. By Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
  2. By Disease-Modifying Antirheumatic Drugs (DMARDs)
  3. By Biologics and Biosimilars
  4. By Corticosteroids
  5. By Others (PDE4 Inhibitors)
4. Global Psoriatic Arthritis (PsA) Treatment Market - by Type of Treatment
  1. By Prescription-based
  2. By Over-the-Counter (OTC)
5. Global Psoriatic Arthritis (PsA) Treatment Market - by Route of Administration
  1. By Oral
  2. By Injectable
  3. By Topical
6. Global Psoriatic Arthritis (PsA) Treatment Market - by Distribution Channel
  1. By Hospital Pharmacies
  2. By Retail Pharmacies
  3. By Online Pharmacies
7. Global Psoriatic Arthritis (PsA) Treatment Market - by region
  1. North America
  2. Europe
  3. Asia Pacific
  4. Latin America
  5. Middle East & Africa
8. Market comparative analysis
North America Psoriatic Arthritis (PsA) Treatment Market - Segment Analysis
1. Overview
2. North America Psoriatic Arthritis (PsA) Treatment Market, 2016 - 2028 (USD Million)
3. North America Psoriatic Arthritis (PsA) Treatment Market, by Drug Class
  1. By Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
  2. By Disease-Modifying Antirheumatic Drugs (DMARDs)
  3. By Biologics and Biosimilars
  4. By Corticosteroids
  5. By Others (PDE4 Inhibitors)
4. North America Psoriatic Arthritis (PsA) Treatment Market, by Type of Treatment
  1. By Prescription-based
  2. By Over-the-Counter (OTC)
5. North America Psoriatic Arthritis (PsA) Treatment Market, by Route of Administration
  1. By Oral
  2. By Injectable
  3. By Topical
6. North America Psoriatic Arthritis (PsA) Treatment Market, by Distribution Channel
  1. By Hospital Pharmacies
  2. By Retail Pharmacies
  3. By Online Pharmacies
7. North America Psoriatic Arthritis (PsA) Treatment Market, by Country
  1. U.S.
    1. U.S. Psoriatic Arthritis (PsA) Treatment Market, By Drug Class
      1. By Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
      2. By Disease-Modifying Antirheumatic Drugs (DMARDs)
      3. By Biologics and Biosimilars
      4. By Corticosteroids
      5. By Others (PDE4 Inhibitors)
    2. U.S. Psoriatic Arthritis (PsA) Treatment Market, By Type of Treatment
      1. By Prescription-based
      2. By Over-the-Counter (OTC)
    3. U.S. Psoriatic Arthritis (PsA) Treatment Market, By Route of Administration
      1. By Oral
      2. By Injectable
      3. By Topical
    4. U.S. Psoriatic Arthritis (PsA) Treatment Market, By Distribution Channel
      1. By Hospital Pharmacies
      2. By Retail Pharmacies
      3. By Online Pharmacies
  2. Canada
    1. Canada Psoriatic Arthritis (PsA) Treatment Market, By Drug Class
      1. By Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
      2. By Disease-Modifying Antirheumatic Drugs (DMARDs)
      3. By Biologics and Biosimilars
      4. By Corticosteroids
      5. By Others (PDE4 Inhibitors)
    2. Canada Psoriatic Arthritis (PsA) Treatment Market, By Type of Treatment
      1. By Prescription-based
      2. By Over-the-Counter (OTC)
    3. Canada Psoriatic Arthritis (PsA) Treatment Market, By Route of Administration
      1. By Oral
      2. By Injectable
      3. By Topical
    4. Canada Psoriatic Arthritis (PsA) Treatment Market, By Distribution Channel
      1. By Hospital Pharmacies
      2. By Retail Pharmacies
      3. By Online Pharmacies
  3. Mexico
    1. Mexico Psoriatic Arthritis (PsA) Treatment Market, By Drug Class
      1. By Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
      2. By Disease-Modifying Antirheumatic Drugs (DMARDs)
      3. By Biologics and Biosimilars
      4. By Corticosteroids
      5. By Others (PDE4 Inhibitors)
    2. Mexico Psoriatic Arthritis (PsA) Treatment Market, By Type of Treatment
      1. By Prescription-based
      2. By Over-the-Counter (OTC)
    3. Mexico Psoriatic Arthritis (PsA) Treatment Market, By Route of Administration
      1. By Oral
      2. By Injectable
      3. By Topical
    4. Mexico Psoriatic Arthritis (PsA) Treatment Market, By Distribution Channel
      1. By Hospital Pharmacies
      2. By Retail Pharmacies
      3. By Online Pharmacies
Europe Psoriatic Arthritis (PsA) Treatment Market - Segment Analysis
1. Overview
2. Europe Psoriatic Arthritis (PsA) Treatment Market, 2016 - 2028 (USD Million)
3. Europe Psoriatic Arthritis (PsA) Treatment Market, by Drug Class
  1. By Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
  2. By Disease-Modifying Antirheumatic Drugs (DMARDs)
  3. By Biologics and Biosimilars
  4. By Corticosteroids
  5. By Others (PDE4 Inhibitors)
4. Europe Psoriatic Arthritis (PsA) Treatment Market, by Type of Treatment
  1. By Prescription-based
  2. By Over-the-Counter (OTC)
5. Europe Psoriatic Arthritis (PsA) Treatment Market, by Route of Administration
  1. By Oral
  2. By Injectable
  3. By Topical
6. Europe Psoriatic Arthritis (PsA) Treatment Market, by Distribution Channel
  1. By Hospital Pharmacies
  2. By Retail Pharmacies
  3. By Online Pharmacies
7. Europe Psoriatic Arthritis (PsA) Treatment Market, by Country
  1. Germany
    1. Germany Psoriatic Arthritis (PsA) Treatment Market, By Drug Class
      1. By Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
      2. By Disease-Modifying Antirheumatic Drugs (DMARDs)
      3. By Biologics and Biosimilars
      4. By Corticosteroids
      5. By Others (PDE4 Inhibitors)
    2. Germany Psoriatic Arthritis (PsA) Treatment Market, By Type of Treatment
      1. By Prescription-based
      2. By Over-the-Counter (OTC)
    3. Germany Psoriatic Arthritis (PsA) Treatment Market, By Route of Administration
      1. By Oral
      2. By Injectable
      3. By Topical
    4. Germany Psoriatic Arthritis (PsA) Treatment Market, By Distribution Channel
      1. By Hospital Pharmacies
      2. By Retail Pharmacies
      3. By Online Pharmacies
  2. UK
    1. UK Market, By Drug Class
      1. By Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
      2. By Disease-Modifying Antirheumatic Drugs (DMARDs)
      3. By Biologics and Biosimilars
      4. By Corticosteroids
      5. By Others (PDE4 Inhibitors)
    2. UK Market, By Type of Treatment
      1. By Prescription-based
      2. By Over-the-Counter (OTC)
    3. UK Market, By Route of Administration
      1. By Oral
      2. By Injectable
      3. By Topical
    4. UK Market, By Distribution Channel
      1. By Hospital Pharmacies
      2. By Retail Pharmacies
      3. By Online Pharmacies
  3. France
    1. France Psoriatic Arthritis (PsA) Treatment Market, By Drug Class
      1. By Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
      2. By Disease-Modifying Antirheumatic Drugs (DMARDs)
      3. By Biologics and Biosimilars
      4. By Corticosteroids
      5. By Others (PDE4 Inhibitors)
    2. France Psoriatic Arthritis (PsA) Treatment Market, By Type of Treatment
      1. By Prescription-based
      2. By Over-the-Counter (OTC)
    3. France Psoriatic Arthritis (PsA) Treatment Market, By Route of Administration
      1. By Oral
      2. By Injectable
      3. By Topical
    4. France Psoriatic Arthritis (PsA) Treatment Market, By Distribution Channel
      1. By Hospital Pharmacies
      2. By Retail Pharmacies
      3. By Online Pharmacies
  4. Spain
    1. Spain Psoriatic Arthritis (PsA) Treatment Market, By Drug Class
      1. By Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
      2. By Disease-Modifying Antirheumatic Drugs (DMARDs)
      3. By Biologics and Biosimilars
      4. By Corticosteroids
      5. By Others (PDE4 Inhibitors)
    2. Spain Psoriatic Arthritis (PsA) Treatment Market, By Type of Treatment
      1. By Prescription-based
      2. By Over-the-Counter (OTC)
    3. Spain Psoriatic Arthritis (PsA) Treatment Market, By Route of Administration
      1. By Oral
      2. By Injectable
      3. By Topical
    4. Spain Psoriatic Arthritis (PsA) Treatment Market, By Distribution Channel
      1. By Hospital Pharmacies
      2. By Retail Pharmacies
      3. By Online Pharmacies
  5. Italy
    1. Italy Psoriatic Arthritis (PsA) Treatment Market, By Drug Class
      1. By Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
      2. By Disease-Modifying Antirheumatic Drugs (DMARDs)
      3. By Biologics and Biosimilars
      4. By Corticosteroids
      5. By Others (PDE4 Inhibitors)
    2. Italy Psoriatic Arthritis (PsA) Treatment Market, By Type of Treatment
      1. By Prescription-based
      2. By Over-the-Counter (OTC)
    3. Italy Psoriatic Arthritis (PsA) Treatment Market, By Route of Administration
      1. By Oral
      2. By Injectable
      3. By Topical
    4. Italy Psoriatic Arthritis (PsA) Treatment Market, By Distribution Channel
      1. By Hospital Pharmacies
      2. By Retail Pharmacies
      3. By Online Pharmacies
  6. BENELUX
    1. BENELUX Psoriatic Arthritis (PsA) Treatment Market, By Drug Class
      1. By Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
      2. By Disease-Modifying Antirheumatic Drugs (DMARDs)
      3. By Biologics and Biosimilars
      4. By Corticosteroids
      5. By Others (PDE4 Inhibitors)
    2. BENELUX Psoriatic Arthritis (PsA) Treatment Market, By Type of Treatment
      1. By Prescription-based
      2. By Over-the-Counter (OTC)
    3. BENELUX Psoriatic Arthritis (PsA) Treatment Market, By Route of Administration
      1. By Oral
      2. By Injectable
      3. By Topical
    4. BENELUX Psoriatic Arthritis (PsA) Treatment Market, By Distribution Channel
      1. By Hospital Pharmacies
      2. By Retail Pharmacies
      3. By Online Pharmacies
  7. Rest of Europe
    1. Rest Of Europe Psoriatic Arthritis (PsA) Treatment Market, By Drug Class
      1. By Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
      2. By Disease-Modifying Antirheumatic Drugs (DMARDs)
      3. By Biologics and Biosimilars
      4. By Corticosteroids
      5. By Others (PDE4 Inhibitors)
    2. Rest Of Europe Psoriatic Arthritis (PsA) Treatment Market, By Type of Treatment
      1. By Prescription-based
      2. By Over-the-Counter (OTC)
    3. Rest Of Europe Psoriatic Arthritis (PsA) Treatment Market, By Route of Administration
      1. By Oral
      2. By Injectable
      3. By Topical
    4. Rest Of Europe Psoriatic Arthritis (PsA) Treatment Market, By Distribution Channel
      1. By Hospital Pharmacies
      2. By Retail Pharmacies
      3. By Online Pharmacies
Asia Pacific Psoriatic Arthritis (PsA) Treatment Market - Segment Analysis
1. Overview
2. Asia Pacific Psoriatic Arthritis (PsA) Treatment Market, 2016 - 2028 (USD Million)
3. Asia Pacific Psoriatic Arthritis (PsA) Treatment Market, by Drug Class
  1. By Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
  2. By Disease-Modifying Antirheumatic Drugs (DMARDs)
  3. By Biologics and Biosimilars
  4. By Corticosteroids
  5. By Others (PDE4 Inhibitors)
4. Asia Pacific Psoriatic Arthritis (PsA) Treatment Market, by Type of Treatment
  1. By Prescription-based
  2. By Over-the-Counter (OTC)
5. Asia Pacific Psoriatic Arthritis (PsA) Treatment Market, by Route of Administration
  1. By Oral
  2. By Injectable
  3. By Topical
6. Asia Pacific Psoriatic Arthritis (PsA) Treatment Market, by Distribution Channel
  1. By Hospital Pharmacies
  2. By Retail Pharmacies
  3. By Online Pharmacies
7. Asia Pacific Psoriatic Arthritis (PsA) Treatment Market, by Country
  1. China
    1. China Psoriatic Arthritis (PsA) Treatment Market, By Drug Class
      1. By Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
      2. By Disease-Modifying Antirheumatic Drugs (DMARDs)
      3. By Biologics and Biosimilars
      4. By Corticosteroids
      5. By Others (PDE4 Inhibitors)
    2. China Psoriatic Arthritis (PsA) Treatment Market, By Type of Treatment
      1. By Prescription-based
      2. By Over-the-Counter (OTC)
    3. China Psoriatic Arthritis (PsA) Treatment Market, By Route of Administration
      1. By Oral
      2. By Injectable
      3. By Topical
    4. China Psoriatic Arthritis (PsA) Treatment Market, By Distribution Channel
      1. By Hospital Pharmacies
      2. By Retail Pharmacies
      3. By Online Pharmacies
  2. Japan
    1. Japan Psoriatic Arthritis (PsA) Treatment Market, By Drug Class
      1. By Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
      2. By Disease-Modifying Antirheumatic Drugs (DMARDs)
      3. By Biologics and Biosimilars
      4. By Corticosteroids
      5. By Others (PDE4 Inhibitors)
    2. Japan Psoriatic Arthritis (PsA) Treatment Market, By Type of Treatment
      1. By Prescription-based
      2. By Over-the-Counter (OTC)
    3. Japan Psoriatic Arthritis (PsA) Treatment Market, By Route of Administration
      1. By Oral
      2. By Injectable
      3. By Topical
    4. Japan Psoriatic Arthritis (PsA) Treatment Market, By Distribution Channel
      1. By Hospital Pharmacies
      2. By Retail Pharmacies
      3. By Online Pharmacies
  3. India
    1. India Psoriatic Arthritis (PsA) Treatment Market, By Drug Class
      1. By Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
      2. By Disease-Modifying Antirheumatic Drugs (DMARDs)
      3. By Biologics and Biosimilars
      4. By Corticosteroids
      5. By Others (PDE4 Inhibitors)
    2. India Psoriatic Arthritis (PsA) Treatment Market, By Type of Treatment
      1. By Prescription-based
      2. By Over-the-Counter (OTC)
    3. India Psoriatic Arthritis (PsA) Treatment Market, By Route of Administration
      1. By Oral
      2. By Injectable
      3. By Topical
    4. India Psoriatic Arthritis (PsA) Treatment Market, By Distribution Channel
      1. By Hospital Pharmacies
      2. By Retail Pharmacies
      3. By Online Pharmacies
  4. South Korea
    1. South Korea Psoriatic Arthritis (PsA) Treatment Market, By Drug Class
      1. By Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
      2. By Disease-Modifying Antirheumatic Drugs (DMARDs)
      3. By Biologics and Biosimilars
      4. By Corticosteroids
      5. By Others (PDE4 Inhibitors)
    2. South Korea Psoriatic Arthritis (PsA) Treatment Market, By Type of Treatment
      1. By Prescription-based
      2. By Over-the-Counter (OTC)
    3. South Korea Psoriatic Arthritis (PsA) Treatment Market, By Route of Administration
      1. By Oral
      2. By Injectable
      3. By Topical
    4. South Korea Psoriatic Arthritis (PsA) Treatment Market, By Distribution Channel
      1. By Hospital Pharmacies
      2. By Retail Pharmacies
      3. By Online Pharmacies
  5. South East Asia
    1. South East Asia Psoriatic Arthritis (PsA) Treatment Market, By Drug Class
      1. By Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
      2. By Disease-Modifying Antirheumatic Drugs (DMARDs)
      3. By Biologics and Biosimilars
      4. By Corticosteroids
      5. By Others (PDE4 Inhibitors)
    2. South East Asia Psoriatic Arthritis (PsA) Treatment Market, By Type of Treatment
      1. By Prescription-based
      2. By Over-the-Counter (OTC)
    3. South East Asia Psoriatic Arthritis (PsA) Treatment Market, By Route of Administration
      1. By Oral
      2. By Injectable
      3. By Topical
    4. South East Asia Psoriatic Arthritis (PsA) Treatment Market, By Distribution Channel
      1. By Hospital Pharmacies
      2. By Retail Pharmacies
      3. By Online Pharmacies
  6. Rest of Asia Pacific
    1. Rest of Asia Pacific Psoriatic Arthritis (PsA) Treatment Market, By Drug Class
      1. By Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
      2. By Disease-Modifying Antirheumatic Drugs (DMARDs)
      3. By Biologics and Biosimilars
      4. By Corticosteroids
      5. By Others (PDE4 Inhibitors)
    2. Rest of Asia Pacific Psoriatic Arthritis (PsA) Treatment Market, By Type of Treatment
      1. By Prescription-based
      2. By Over-the-Counter (OTC)
    3. Rest of Asia Pacific Psoriatic Arthritis (PsA) Treatment Market, By Route of Administration
      1. By Oral
      2. By Injectable
      3. By Topical
    4. Rest of Asia Pacific Psoriatic Arthritis (PsA) Treatment Market, By Distribution Channel
      1. By Hospital Pharmacies
      2. By Retail Pharmacies
      3. By Online Pharmacies
Latin America Psoriatic Arthritis (PsA) Treatment Market - Segment Analysis
1. Overview
2. Latin America Psoriatic Arthritis (PsA) Treatment Market, 2016 - 2028 (USD Million)
3. Latin America Psoriatic Arthritis (PsA) Treatment Market, by Drug Class
  1. By Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
  2. By Disease-Modifying Antirheumatic Drugs (DMARDs)
  3. By Biologics and Biosimilars
  4. By Corticosteroids
  5. By Others (PDE4 Inhibitors)
4. Latin America Psoriatic Arthritis (PsA) Treatment Market, by Type of Treatment
  1. By Prescription-based
  2. By Over-the-Counter (OTC)
5. Latin America Psoriatic Arthritis (PsA) Treatment Market, by Route of Administration
  1. By Oral
  2. By Injectable
  3. By Topical
6. Latin America Psoriatic Arthritis (PsA) Treatment Market, by Distribution Channel
  1. By Hospital Pharmacies
  2. By Retail Pharmacies
  3. By Online Pharmacies
7. Latin America Psoriatic Arthritis (PsA) Treatment Market, by Country
  1. Brazil
    1. Brazil Psoriatic Arthritis (PsA) Treatment Market, By Drug Class
      1. By Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
      2. By Disease-Modifying Antirheumatic Drugs (DMARDs)
      3. By Biologics and Biosimilars
      4. By Corticosteroids
      5. By Others (PDE4 Inhibitors)
    2. Brazil Psoriatic Arthritis (PsA) Treatment Market, By Type of Treatment
      1. By Prescription-based
      2. By Over-the-Counter (OTC)
    3. Brazil Psoriatic Arthritis (PsA) Treatment Market, By Route of Administration
      1. By Oral
      2. By Injectable
      3. By Topical
    4. Brazil Psoriatic Arthritis (PsA) Treatment Market, By Distribution Channel
      1. By Hospital Pharmacies
      2. By Retail Pharmacies
      3. By Online Pharmacies
  2. Argentina
    1. Argentina Psoriatic Arthritis (PsA) Treatment Market, By Drug Class
      1. By Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
      2. By Disease-Modifying Antirheumatic Drugs (DMARDs)
      3. By Biologics and Biosimilars
      4. By Corticosteroids
      5. By Others (PDE4 Inhibitors)
    2. Argentina Psoriatic Arthritis (PsA) Treatment Market, By Type of Treatment
      1. By Prescription-based
      2. By Over-the-Counter (OTC)
    3. Argentina Psoriatic Arthritis (PsA) Treatment Market, By Route of Administration
      1. By Oral
      2. By Injectable
      3. By Topical
    4. Argentina Psoriatic Arthritis (PsA) Treatment Market, By Distribution Channel
      1. By Hospital Pharmacies
      2. By Retail Pharmacies
      3. By Online Pharmacies
  3. Rest of Latin America
    1. Rest of Latin America Psoriatic Arthritis (PsA) Treatment Market, By Drug Class
      1. By Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
      2. By Disease-Modifying Antirheumatic Drugs (DMARDs)
      3. By Biologics and Biosimilars
      4. By Corticosteroids
      5. By Others (PDE4 Inhibitors)
    2. Rest of Latin America Psoriatic Arthritis (PsA) Treatment Market, By Type of Treatment
      1. By Prescription-based
      2. By Over-the-Counter (OTC)
    3. Rest of Latin America Psoriatic Arthritis (PsA) Treatment Market, By Route of Administration
      1. By Oral
      2. By Injectable
      3. By Topical
    4. Rest of Latin America Psoriatic Arthritis (PsA) Treatment Market, By Distribution Channel
      1. By Hospital Pharmacies
      2. By Retail Pharmacies
      3. By Online Pharmacies
Middle East & Africa Psoriatic Arthritis (PsA) Treatment Market - Segment Analysis
1. Overview
2. Middle East & Africa Psoriatic Arthritis (PsA) Treatment Market, 2016 - 2028 (USD Million)
3. Middle East & Africa Psoriatic Arthritis (PsA) Treatment Market, by Drug Class
  1. By Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
  2. By Disease-Modifying Antirheumatic Drugs (DMARDs)
  3. By Biologics and Biosimilars
  4. By Corticosteroids
  5. By Others (PDE4 Inhibitors)
4. Middle East & Africa Psoriatic Arthritis (PsA) Treatment Market, by Type of Treatment
  1. By Prescription-based
  2. By Over-the-Counter (OTC)
5. Middle East & Africa Psoriatic Arthritis (PsA) Treatment Market, by Route of Administration
  1. By Oral
  2. By Injectable
  3. By Topical
6. Middle East & Africa Psoriatic Arthritis (PsA) Treatment Market, by Distribution Channel
  1. By Hospital Pharmacies
  2. By Retail Pharmacies
  3. By Online Pharmacies
7. Middle East & Africa Psoriatic Arthritis (PsA) Treatment Market, by Country
  1. GCC Countries
    1. GCC Countries Psoriatic Arthritis (PsA) Treatment Market, By Drug Class
      1. By Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
      2. By Disease-Modifying Antirheumatic Drugs (DMARDs)
      3. By Biologics and Biosimilars
      4. By Corticosteroids
      5. By Others (PDE4 Inhibitors)
    2. GCC Countries Psoriatic Arthritis (PsA) Treatment Market, By Type of Treatment
      1. By Prescription-based
      2. By Over-the-Counter (OTC)
    3. GCC Countries Psoriatic Arthritis (PsA) Treatment Market, By Route of Administration
      1. By Oral
      2. By Injectable
      3. By Topical
    4. GCC Countries Psoriatic Arthritis (PsA) Treatment Market, By Distribution Channel
      1. By Hospital Pharmacies
      2. By Retail Pharmacies
      3. By Online Pharmacies
  2. South Africa
    1. South Africa Psoriatic Arthritis (PsA) Treatment Market, By Drug Class
      1. By Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
      2. By Disease-Modifying Antirheumatic Drugs (DMARDs)
      3. By Biologics and Biosimilars
      4. By Corticosteroids
      5. By Others (PDE4 Inhibitors)
    2. South Africa Psoriatic Arthritis (PsA) Treatment Market, By Type of Treatment
      1. By Prescription-based
      2. By Over-the-Counter (OTC)
    3. South Africa Psoriatic Arthritis (PsA) Treatment Market, By Route of Administration
      1. By Oral
      2. By Injectable
      3. By Topical
    4. South Africa Psoriatic Arthritis (PsA) Treatment Market, By Distribution Channel
      1. By Hospital Pharmacies
      2. By Retail Pharmacies
      3. By Online Pharmacies
  3. Rest of Middle East & Africa
    1. Rest of Middle East & Africa Psoriatic Arthritis (PsA) Treatment Market, By Drug Class
      1. By Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
      2. By Disease-Modifying Antirheumatic Drugs (DMARDs)
      3. By Biologics and Biosimilars
      4. By Corticosteroids
      5. By Others (PDE4 Inhibitors)
    2. Rest of Middle East & Africa Psoriatic Arthritis (PsA) Treatment Market, By Type of Treatment
      1. By Prescription-based
      2. By Over-the-Counter (OTC)
    3. Rest of Middle East & Africa Psoriatic Arthritis (PsA) Treatment Market, By Route of Administration
      1. By Oral
      2. By Injectable
      3. By Topical
    4. Rest of Middle East & Africa Psoriatic Arthritis (PsA) Treatment Market, By Distribution Channel
      1. By Hospital Pharmacies
      2. By Retail Pharmacies
      3. By Online Pharmacies
Key Market Dynamics
1. Introduction
2. Market Drivers
3. Market Restraints
4. Market Opportunities
5. Porter's Five Forces Analysis
6. PEST Analysis
7. Regulatory Landscape
8. Technology Landscape
9. Regional Market Trends
COVID 19 Impact Analysis
1. Key strategies undertaken by companies to tackle COVID-19
2. Short term dynamics
3. Long term dynamics
Marketing Stratagy Analysis
1. Marketing Channel
2. Direct Marketing
3. Indirect Marketing
4. Marketing Channel Development Trends
Competative Landscape
1. Competition Matrix - 2021
2. Company Market Share Analysis - 2021
3. Key Company Activities, 2018 - 2021
4. Strategic Developments - Heat Map Analysis
5. Company Offering Evaluation
6. Company Regional Presence Evaluation
Company Profiles
1. AbbVie Inc.
2. Amgen Inc.
3. Johnson & Johnson (Janssen Pharmaceuticals)
4. Pfizer Inc.
5. Bristol-Myers Squibb
6. Novartis AG
7. UCB S.A.
8. Eli Lilly and Company
9. Biogen
10. Merck KGaA
11. Sanofi
12. Teva Pharmaceuticals
13. Fujifilm Kyowa Kirin Biologics
14. Samsung Bioepis
15. Sun Pharmaceutical Industries.
Key Primary Respondents - VERBATIM
Discussion Guide
Customization Offered
Annexure
List of Figures
List of Tables
List of Abbreviations

FAQ

Frequently Asked Question

What is the global demand for Psoriatic Arthritis (PsA) Treatment in terms of revenue?

The global Psoriatic Arthritis (PsA) Treatment valued at USD 24.01 Billion in 2024 and is expected to reach USD 50.45 Billion in 2034 growing at a CAGR of 8.6%.

Which are the prominent players in the market?

The prominent players in the market are AbbVie Inc., Amgen Inc., Johnson & Johnson (Janssen Pharmaceuticals), Pfizer Inc., Bristol-Myers Squibb, Novartis AG, UCB S.A., Eli Lilly and Company, Biogen, Merck KGaA, Sanofi, Teva Pharmaceuticals, Fujifilm Kyowa Kirin Biologics, Samsung Bioepis, Sun Pharmaceutical Industries..

At what CAGR is the market projected to grow within the forecast period?

The market is project to grow at a CAGR of 8.6% between 2025 and 2034.

What are the driving factors fueling the growth of the market.

The driving factors of the Psoriatic Arthritis (PsA) Treatment include

Which region accounted for the largest share in the market?

North America was the leading regional segment of the Psoriatic Arthritis (PsA) Treatment in 2024.

Psoriatic Arthritis (PsA) Treatment Market

Psoriatic Arthritis (PsA) Treatment Market - Global Industry Assessment & Forecast

Healthcare

Segments Covered

Snapshot

Customization Offered

FAQ

Frequently Asked Question

What is the global demand for Psoriatic Arthritis (PsA) Treatment in terms of revenue?

Which are the prominent players in the market?

At what CAGR is the market projected to grow within the forecast period?

What are the driving factors fueling the growth of the market.

Which region accounted for the largest share in the market?

Quick Links

For Buying Inquiry

Psoriatic Arthritis (PsA) Treatment Market

Psoriatic Arthritis (PsA) Treatment Market - Global Industry Assessment & Forecast

Healthcare

Segments Covered

Snapshot

Customization Offered

FAQ

Frequently Asked Question

What is the global demand for Psoriatic Arthritis (PsA) Treatment in terms of revenue?

Which are the prominent players in the market?

At what CAGR is the market projected to grow within the forecast period?

What are the driving factors fueling the growth of the market.

Which region accounted for the largest share in the market?

Related Reports

Request Sample Report for Psoriatic Arthritis (PsA) Treatment Market

Vantage Point Interactive Dashboard